Cargando…
Evidence for positive selection on Mycobacterium tuberculosis within patients
BACKGROUND: While the pathogenesis and epidemiology of tuberculosis are well studied, relatively little is known about the evolution of the infectious agent Mycobacterium tuberculosis, especially at the within-host level. The insertion sequence IS6110 is a genetic marker that is widely used to track...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC518962/ https://www.ncbi.nlm.nih.gov/pubmed/15355550 http://dx.doi.org/10.1186/1471-2148-4-31 |
_version_ | 1782121802278895616 |
---|---|
author | Tanaka, Mark M |
author_facet | Tanaka, Mark M |
author_sort | Tanaka, Mark M |
collection | PubMed |
description | BACKGROUND: While the pathogenesis and epidemiology of tuberculosis are well studied, relatively little is known about the evolution of the infectious agent Mycobacterium tuberculosis, especially at the within-host level. The insertion sequence IS6110 is a genetic marker that is widely used to track the transmission of tuberculosis between individuals. This and other markers may also facilitate our understanding of the disease within patients. RESULTS: This article presents three lines of evidence supporting the action of positive selection on M. tuberculosis within patients. The arguments are based on a comparison between empirical findings from molecular epidemiology, and population genetic models of evolution. Under the hypothesis of neutrality of genotypes, 1) the mutation rate of the marker IS6110 is unusually high, 2) the time it takes for substitutions to occur within patients is too short, and 3) the amount of polymorphism within patients is too low. CONCLUSIONS: Empirical observations are explained by the action of positive selection during infection, or alternatively by very low effective population sizes. I discuss the possible roles of antibiotic treatment, the host immune system and extrapulmonary dissemination in creating opportunities for positive selection. |
format | Text |
id | pubmed-518962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-5189622004-09-26 Evidence for positive selection on Mycobacterium tuberculosis within patients Tanaka, Mark M BMC Evol Biol Research Article BACKGROUND: While the pathogenesis and epidemiology of tuberculosis are well studied, relatively little is known about the evolution of the infectious agent Mycobacterium tuberculosis, especially at the within-host level. The insertion sequence IS6110 is a genetic marker that is widely used to track the transmission of tuberculosis between individuals. This and other markers may also facilitate our understanding of the disease within patients. RESULTS: This article presents three lines of evidence supporting the action of positive selection on M. tuberculosis within patients. The arguments are based on a comparison between empirical findings from molecular epidemiology, and population genetic models of evolution. Under the hypothesis of neutrality of genotypes, 1) the mutation rate of the marker IS6110 is unusually high, 2) the time it takes for substitutions to occur within patients is too short, and 3) the amount of polymorphism within patients is too low. CONCLUSIONS: Empirical observations are explained by the action of positive selection during infection, or alternatively by very low effective population sizes. I discuss the possible roles of antibiotic treatment, the host immune system and extrapulmonary dissemination in creating opportunities for positive selection. BioMed Central 2004-09-09 /pmc/articles/PMC518962/ /pubmed/15355550 http://dx.doi.org/10.1186/1471-2148-4-31 Text en Copyright © 2004 Tanaka; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tanaka, Mark M Evidence for positive selection on Mycobacterium tuberculosis within patients |
title | Evidence for positive selection on Mycobacterium tuberculosis within patients |
title_full | Evidence for positive selection on Mycobacterium tuberculosis within patients |
title_fullStr | Evidence for positive selection on Mycobacterium tuberculosis within patients |
title_full_unstemmed | Evidence for positive selection on Mycobacterium tuberculosis within patients |
title_short | Evidence for positive selection on Mycobacterium tuberculosis within patients |
title_sort | evidence for positive selection on mycobacterium tuberculosis within patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC518962/ https://www.ncbi.nlm.nih.gov/pubmed/15355550 http://dx.doi.org/10.1186/1471-2148-4-31 |
work_keys_str_mv | AT tanakamarkm evidenceforpositiveselectiononmycobacteriumtuberculosiswithinpatients |